Article
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer
15 Mar 2021
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal forms of human cancer, characterized by unrestrained progression, invasiveness and treatment resistance. To date, there are limited curative options, with surgical resection as the only effective strategy, hence the urgent need to discover novel therapies. A platform of onco-immunology targets is represented by molecules that play a role in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
